STK11/LKB1 Loss of Function Is Associated with Global DNA Hypomethylation and S-Adenosyl-Methionine Depletion in

Michael J Koenig1, Bernice A Agana2, Jacob M Kaufman3

  • 1Department of Internal Medicine, The Ohio State University, Columbus, Ohio. David.Carbone@osumc.edu Koenig.82@osu.edu.

Cancer Research
|May 28, 2021
PubMed

Insights

Lung adenocarcinoma with STK11 (LKB1) loss shows widespread DNA hypomethylation. This epigenetic change is linked to altered gene expression and may impact cancer treatment strategies.

Area of Science:

  • Oncology
  • Epigenetics
  • Genomics

Background:

  • STK11 (liver kinase B1, LKB1) is frequently mutated in lung adenocarcinoma.
  • LKB1 loss of function occurs in up to 30% of lung adenocarcinoma cases.
  • A 16-gene signature for LKB1 loss was previously identified.

Purpose of the Study:

  • To investigate the epigenetic consequences of LKB1 loss in lung adenocarcinoma.
  • To apply a 16-gene signature to TCGA lung adenocarcinoma samples.
  • To uncover novel associations between LKB1 status and DNA methylation.

Main Methods:

  • Application of a 16-gene signature to TCGA lung adenocarcinoma data.
  • Analysis of S-adenosyl-methionine (SAM-e) levels in tumors.
  • Assessment of DNA methylation patterns, including repetitive elements (RE).
  • Evaluation of FOXA family protein expression and localization.

Main Results:

  • LKB1-deficient tumors exhibited widespread DNA demethylation.
  • Depletion of SAM-e, the substrate for DNMT1, was observed in LKB1-deficient tumors.
  • Hypomethylation affected repetitive elements, altering their transcription.
  • Decreased sensitivity to azacytidine was noted in LKB1-deficient tumors.
  • Demethylated CpGs were enriched for FOXA binding sites, with FOXA expression dependent on LKB1.

Conclusions:

  • LKB1 loss drives global hypomethylation in a significant subset of lung adenocarcinomas.
  • This epigenetic dysregulation involves SAM-e depletion and altered RE transcription.
  • Findings have implications for epigenetic therapy and immunotherapy in LKB1-mutant lung cancers.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.3K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.8K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K